Source comparison
CJC-1295 no DAC & Ipamorelin 50s Age Specific Protocol: Dosing Comparison
Under 40 100mcg 100–200mcg 5–7×/week Daily pre-sleep or post-training Standard protocol. Sufficient pituitary reserve supports daily stimulation without desensitization 40–50 100–150mcg 150–250mcg 4–5×/week Alternating pre-sleep and post-training Transition pr
This comparison does not assign a generated winner or score.
- Under 40
- 100mcg
- 100–200mcg
- 5–7×/week
- Daily pre-sleep or post-training
- Standard protocol. Sufficient pituitary reserve supports daily stimulation without desensitization
- 40–50
- 100–150mcg
- 150–250mcg
- 4–5×/week
- Alternating pre-sleep and post-training
- Transition protocol. Pituitary response begins declining, frequency reduction prevents receptor fatigue
- 50+
- 200–300mcg
- 3–4×/week
- Pre-sleep (2×/week) + post-training (1–2×/week)
- Age-adjusted protocol. Higher per-dose amounts compensate for blunted response; reduced frequency preserves receptor sensitivity across week
- 60+
- 150–200mcg
- 250–300mcg
- 3×/week
- Strict pre-sleep alignment
- Conservative protocol. Circadian GH machinery weakest; all injections timed to strongest remaining pulse window